CTSK and breast carcinoma: For example, in transgenic mouse models of pancreatic duct adenocarcinoma, breast cancer cells, and myeloid-derived suppressor cells, reduced expression of cathepsin B was compensated by cathepsin X/Z in breast cancer cells [5].